Your browser doesn't support javascript.
loading
Development of an oral suspension containing dry extract of Aleurites moluccanus with anti-inflammatory activity
Donald, Richie Mac; Camargo, Sabrina Santana; Meyre-Silva, Christiane; Quintão, Nara Lins Meira; Cechinel Filho, Valdir; Bresolin, Tania Mari Bellé; Lucinda-Silva, Ruth Meri.
  • Donald, Richie Mac; Universidade do Vale do Itajaí. Programa de Pós-graduação em Ciências Farmacêuticas. Itajaí. BR
  • Camargo, Sabrina Santana; Universidade do Vale do Itajaí. Programa de Pós-graduação em Ciências Farmacêuticas. Itajaí. BR
  • Meyre-Silva, Christiane; Universidade do Vale do Itajaí. Programa de Pós-graduação em Ciências Farmacêuticas. Itajaí. BR
  • Quintão, Nara Lins Meira; Universidade do Vale do Itajaí. Programa de Pós-graduação em Ciências Farmacêuticas. Itajaí. BR
  • Cechinel Filho, Valdir; Universidade do Vale do Itajaí. Programa de Pós-graduação em Ciências Farmacêuticas. Itajaí. BR
  • Bresolin, Tania Mari Bellé; Universidade do Vale do Itajaí. Programa de Pós-graduação em Ciências Farmacêuticas. Itajaí. BR
  • Lucinda-Silva, Ruth Meri; Universidade do Vale do Itajaí. Programa de Pós-graduação em Ciências Farmacêuticas. Itajaí. BR
Rev. bras. farmacogn ; 26(1): 68-76, Jan.-Feb. 2016. tab, graf
Article en En | LILACS | ID: lil-772648
Biblioteca responsable: BR1.1
ABSTRACT
Abstract Aleurites moluccanus L. (Willd.), Euphorbiaceae, is a tree that is native to Indonesia and India. Various parts of this tree are commonly used in traditional medicine to treat pain, fever, inflammation, hepatitis, gastric ulcer and other ailments. An oral suspension containing dried extract of A. moluccanus was developed and in vivo anti-inflammatory activity was evaluated. Extract 100 and 50 mg/ml loaded oral suspensions were prepared using different suspending agents. The formulations were analysed by their appearance, pH, density, redispersion time, rate of settling, rheological behaviour, distribution of particle size and zeta potential. The dose uniformity was determined by measuring the content of total phenolic compounds expressed in swertisin by a validated HPLC method, as well as the dissolution profile. The stability of oral suspensions was analysed in accelerated studies (40 °C for 6 months). The anti-inflammatory activity was analysed using an in vivo paw oedema model. The taste and odour of the suspensions were shown to be characteristic of the extract. Carmellose sodium (CS; 0.5%) and microcrystalline cellulose and carmellose sodium mixture (MCCS; 1%) showed better physical behaviour. The content of total phenolic compounds was 1.6 mg/ml and approximately 100% of the total phenolic compounds dissolved within 10 min. During the stability study, the formulations were approved by their physical–chemical properties and were shown to lose 12–14% of total phenolic compounds at 40 °C after 6 months. Suspensions containing 50 mg/ml of standardised dried extract inhibited around 35 ± 7.6% of paw oedema. Formulations containing CS showed more anti-inflammatory activity. Suspensions containing dry extract of A. moluccanus were successfully obtained and showed physical and physical–chemistry properties that were appropriate and characteristic of this dosage form, suitable for administration in paediatric and elderly populations, making this an alternative to tablets.
Palabras clave

Texto completo: 1 Banco de datos: LILACS Tipo de estudio: Prognostic_studies Idioma: En Año: 2016 Tipo del documento: Article / Project document

Texto completo: 1 Banco de datos: LILACS Tipo de estudio: Prognostic_studies Idioma: En Año: 2016 Tipo del documento: Article / Project document